Tomohiro Miyoshi

11PUBLICATIONS
36CO-AUTHORS
Oncology and carcinogenesis not elsewhere classifiedLiquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)OtorhinolaryngologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 24, 2026
Oncologic Safety of Omitting Mediastinal Lymph Node Dissection in Segmentectomy for Ground-Glass Opacity-Dominant Lung Cancer: A Supplementary Analysis of JCOG1211.

|Feb 05, 2026
Function-preserving radical surgery for early-stage non-small cell lung cancer: A review of limited resection approaches.

Yoichi Ohtaki, Keiju Aokage, Tomohiro Miyoshi

|Oct 25, 2024
Efficacy, Safety, and Influence on the Tumor Microenvironment of Neoadjuvant Pembrolizumab plus Ramucirumab for PD-L1-Positive NSCLC: A Phase II Trial (EAST ENERGY).

Keiju Aokage, Shohei Koyama, Shogo Kumagai

|Sep 10, 2024
The effect of epidermal growth factor receptor mutation on adjuvant chemotherapy with tegafur/uracil for patients with completely resected, non-lymph node metastatic non-small cell lung cancer (> 2 cm): a multicenter, retrospective, observational study as exploratory analysis of the CSPOR-LC03 study.

Tomohiro Miyoshi, Keiju Aokage, Shun-Ichi Watanabe

|Aug 19, 2024
The Lung Cancer Surgical Study Group of the Japan Clinical Oncology Group: outstanding contribution and entering a new phase.

Kazuo Nakagawa, Masaya Yotsukura, Takahiro Mimae

|Mar 08, 2024
Spatial intratumor heterogeneity of programmed death-ligand 1 expression predicts poor prognosis in resected non-small cell lung cancer.

Yusuke Nagasaki, Tetsuro Taki, Kotaro Nomura

Pageof 2

Frequent Collaborators

6 joint publications

Keiju Aokage

4 joint publications

Takahiro Mimae

3 joint publications

Kenji Suzuki

3 joint publications

Joji Samejima